*  Exposure Controls/Personal Protection  *
Respiratory Protection:IF VAPOR CONCENTRATION EXCEEDS TLV LISTED IN ING
    SECTION, USE NIOSH/MSHA APPROVED RESPIRATOR WITH ORGANIC CHEMICAL
    CARTRIDGE. CONSULT A REPUTABLE SAFETY SUPPLY COMPANY FOR PROPER
    RESPIRATOR SELECTION.
Ventilation:GENERAL/LOC EXHAUST IN VOL/PATN TO KEEP TLV OF MOST HAZ
    INGRED BLW STATED LIM, & TO REMOVE DECOMP PROD DURING (SUPDAT)
Other Protective Equipment:PROTECTIVE CLOTHING TO PREVENT SKIN CONTACT.
Work Hygienic Practices:WASH WITH SOAP AND WATER BEFORE EATING, SMOKING
    OR USING TOILET FACILITIES.
Supplemental Safety and Health
EXPLOS HAZ:PRESS BUILDUP & POSS AUTOIGNIT/EXPLOS IF EXPOSED TO EXTREME
    HEAT. IF WATER IS USED, FOG NOZZLES ARE PREF. VENT:WELDING OR FLAME
    CUTTING ON SURFACE COATED WITH PRODUCT.
*  Product Identification  *
*  Composition/Information on Ingredients  *
Ingred Name:ETHANOL, 2-BUTOXY-, ACETATE; (ETHYLENE GLYCOL MONOBUTYL
Ingred Name:PROPIONIC ACID, 3-ETHYL-, ETHYL ESTER;
Fraction by Wt: 6-8%
Fraction by Wt: 3-4%
*  Hazards Identification  *
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NOOSHA:NO
Health Hazards Acute and Chronic:ANIMAL STUDIES CLEARLY DEMONSTRATED
    DOSE-RELATED ADVERSE EFFECTS IN CNS, HEMATOPOIETIC TISSUE, BLOOD,
    KIDNEY AND LIVER, ASSOCIATED WITH ADMINISTRATION OF ETHYLENE GLYCOL
    MONOBUTYL ETHER ACETATE (EGBEA ). EXTRACTED FROM DHHS (NIOSH) PUB
Explanation of Carcinogenicity:NOT RELEVANT
Effects of Overexposure:EYES:MAY CAUSE SEV IRRIT. SKIN:MAY CAUSE IRRIT.
    INHAL:MAY CAUSE RESP TRACT IRRIT. RPTD/PRLNGD OVEREXPOS BY
    IHAL/SKIN ABSORP MAY CAUSE KIDNEY, LIVER & BLOOD DMG. REPORTS HAVE
    ASSOC RPTD/PRLNGD OCCUP OV EREXPOS TO SOLV W/PERM BRAIN & NERVOUS
    SYS DMG. INT MISUSE BY DELIB CONCEN & INHAL CONTENTS MAY BE
    HARMFUL/FATAL.
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.
*  First Aid Measures  *
First Aid:INHAL:REMOVE FROM EXPOSURE. RESTORE BREATHING. KEEP WARM AND
    QUIET. NOTIFY MD. EYES:FLUSH IMMEDIATELY WITH COPIOUS AMOUNTS OF
    TREATM ENT. SKIN:REMOVE WITH SOAP AND WATER. REMOVE CONTAMINATED
    CLOTHING. INGEST:CALL MD IMMEDIATELY .
*  Fire Fighting Measures  *
Flash Point Method:TCC
Extinguishing Media:FOAM, CARBON DIOXIDE, DRY CHEMICAL.
Fire Fighting Procedures:USE NIOSH/MSHA APPROVED SCBA AND FULL
    PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:CLSD CONTR MAY EXPLODE WHEN EXPOSED TO
    EXTREME HEAT. DO NOT APPLY TO HOT SURF. H*2O SPRAY MAY BE INEFT.
    H*2O MAY BE USED TO COOL CLSD CONTR TO PREVENT (SUPDAT)
*  Accidental Release Measures  *
Spill Release Procedures:REMOVE ALL SOURCES OF IGNITION (FLAMES, HOT
    SURFACES AND ELECTRICAL, STATIC OR FRICTIONAL SPARKS). AVOID
    BREATHING VAPORS. VENTILATE AREA. REMOVE WITH INERT ABSORBENT AND
    NON-SPARKING TOOLS.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
*Handling and Storage  *
    AMTS IN BUILDING DESIGNED FOR STORAGE OF NFPA CLASS II COMBUST LIQ.
    KEEP CONTR TIGHTLY CLSD.
Other Precautions:DO NOT TAKE INTERNALLY. CONTAINERS SHOULD BE GROUNDED
    WHEN POURING. AVOID FREE FALL OF LIQUIDS IN EXCESS OF A FEW INCHES.
    DO NOT FLAME CUT, BRAZE OR WELD WITHOUT NIOSH/MSHA APPROVED RESP OR
    APPROP VEN T.
*  Physical/Chemical Properties  *
HCC:F4
Vapor Pres:SEE ING
Evaporation Rate & Reference:SLOWER THAN ETHER
Appearance and Odor:NONE SPECIFIED BY MANUFACTURER.
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
NONE SPECIFIED BY MANUFACTURER.
Stability Condition to Avoid:HEAT, ELECTRICAL EQUIPMENT, SPARKS AND
    OPEN FLAMES.
Hazardous Decomposition Products:MAY PROD HAZ FUMED WHEN HEATED TO
    DECOMP AS IN WELDING. FUMES MAY CONTAIN CO, NO*X AND HYDROGEN
    CHLORIDE.
*  Disposal Considerations  *
Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH APPLICABLE LOCAL,
    COUNTY, STATE AND FEDERAL REGULATIONS. DO NOT INCINERATE CLOSED
    CONTAINERS.
